MNG Direct Announces Appointment of Stephen Wray as Chief Executive Officer and the Promotion of Chris Wiltshire to Chairman of the Board

16 Feb, 2016, 19:50 ET from Insignia Capital Group

BENSALEM, Pa., Feb. 16, 2016 /PRNewswire/ -- MNG Direct, today announced it has appointed Stephen Wray as Chief Executive Officer and promoted Chris Wiltshire to Chairman of the Board of Directors of the company. Recently acquired by Insignia Capital Group, MNG Direct provides technology-enabled marketing solutions for brands to cost-effectively connect with healthcare providers through a variety of channels.

Prior to joining MNG Direct, Steve served as the CEO and President of Cadient, a Cognizant Company. He served in that capacity from 2004, leading the company through a period of sustained growth and driving the sale of the business to Cognizant (NASDAQ: CTSH). Steve was formerly the North American Regional President and CEO, US for Ogilvy Healthworld, part of the WPP network of agencies. His career experience also includes his role as Vice President of Marketing Communications for Wyeth and service on the boards of privately held companies and philanthropic organizations.

Chris Wiltshire joined MNG Direct in 2007 and previously served as President. "Chris is an invaluable member of the MNG Direct team whose contributions have led the transformation of MNG Direct to its position today as a preeminent provider of multichannel marketing services to the healthcare industry. Chris' promotion to Chairman of the Board reflects our appreciation for everything he has contributed to the company to date and the value he will add going forward," said Tony Broglio, a Partner at Insignia. 

"On behalf of the entire team at MNG Direct, I'm thrilled to welcome Steve to our organization. We are looking forward to collaborating with him to continue to expand the relevance of our solutions to our Life Sciences customers, fueling company growth and enhancing the careers of our employees," said Chris Wiltshire.

"I am very excited to join Chris and the rest of the team at MNG Direct," Steve Wray said. "At a time when reduced access to healthcare practitioners is limiting the ability of pharmaceutical, biotechnology and medical device companies to reach key constituents, MNG Direct's solutions efficiently and effectively expand access to HCPs through a variety of channels. The industry has only recently begun to leverage marketing automation as a core strategy to drive relevant customer engagement – our vision at MNG is to the lead this evolution, defining a new category of solutions for life sciences brands."

"We are delighted to bring Steve's expertise to the company," said Tony Broglio. "His wide range of healthcare experience, keen understanding of multichannel marketing, and leadership skills will be huge assets in the company's continued growth. The appointment of Steve as CEO and promotion of Chris to Chairman puts us in a great position to continue to serve our clients' growing needs and produce a successful outcome for all stakeholders."

About MNG Direct
Based in Bensalem, PA, MNG Direct builds data-driven multichannel marketing solutions that provide 100% target HCP reach and the highest engagement rates in the industry for pharmaceutical, biotechnology, and medical device brands. For more information on MNG Direct, visit us at http://www.mngdirect.com.

About Insignia Capital Group
Insignia Capital Group is a private equity firm based in the San Francisco Bay Area focused on investing in lower middle-market businesses where it can partner with leading management teams to achieve their true business potential. The firm's principals have significant experience building businesses across a range of industries including healthcare, business services and consumer.  For more information please visit www.insigniacap.com.

 

SOURCE Insignia Capital Group



RELATED LINKS

insigniacap.com